Cargando…
The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
BACKGROUND AND AIMS: Alcoholic hepatitis (AH) is characterized by acute liver failure, neurocognitive impairment and renal failure. Severe inflammatory reactions are also known to occur in AH. Inflammation and bacterial translocation in the gut are thought to have major impact on disease development...
Autores principales: | Kimer, Nina, Meldgaard, Mads, Hamberg, Ole, Kronborg, Thit Mynster, Lund, Allan M., Møller, Holger Jon, Bendtsen, Flemming, Ytting, Henriette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920190/ https://www.ncbi.nlm.nih.gov/pubmed/35286322 http://dx.doi.org/10.1371/journal.pone.0264278 |
Ejemplares similares
-
Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study
por: Kronborg, Thit Mynster, et al.
Publicado: (2021) -
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
por: Mynster Kronborg, Thit, et al.
Publicado: (2023) -
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
por: Kimer, Nina, et al.
Publicado: (2018) -
Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy
por: Kimer, Nina, et al.
Publicado: (2014) -
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
por: Kronborg, Thit M., et al.
Publicado: (2023)